Stockscreener 앱 받기
0.36%
시간 외 거래:
전일 마감가:
$44.24
열려 있는:
$44.24
하루 거래량:
4.41M
Relative Volume:
0.83
시가총액:
$11.63B
수익:
$14.00B
순이익/손실:
$1.26B
주가수익비율:
9.0422
EPS:
4.8749
순현금흐름:
$352.00M
1주 성능:
+1.38%
1개월 성능:
-18.52%
6개월 성능:
-26.11%
1년 성능:
+42.93%
1일 변동 폭
$43.50
$44.66
1주일 범위
$43.41
$47.03
52주 변동 폭
$28.11
$84.38
알코아 Stock (AA) Company Profile
명칭
Agilent Technologies Inc
전화
412-315-2900
주소
201 ISABELLA STREET, PITTSBURGH, PA
Compare AA vs TMO, DHR, IDXX, A, NTRA
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AA
Agilent Technologies Inc
|
44.08 | 11.67B | 14.00B | 1.26B | 352.00M | 4.8749 |
TMO
Thermo Fisher Scientific Inc
|
559.53 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
556.20 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
137.89 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
258.03 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
알코아 Stock (AA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-09 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2026-03-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2026-01-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2026-01-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2026-01-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-08 | 개시 | Wells Fargo | Overweight |
| 2025-07-08 | 재개 | Citigroup | Buy |
| 2025-05-15 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-04-08 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-10-23 | 업그레이드 | Argus | Hold → Buy |
| 2024-10-17 | 업그레이드 | B. Riley Securities | Neutral → Buy |
| 2024-10-01 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-09-25 | 재개 | JP Morgan | Neutral |
| 2024-09-04 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2024-08-12 | 업그레이드 | UBS | Sell → Buy |
| 2024-08-02 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-06-21 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-04-22 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-01-16 | 개시 | UBS | Sell |
| 2023-12-07 | 개시 | HSBC Securities | Hold |
| 2023-10-23 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-07-24 | 다운그레이드 | Argus | Buy → Hold |
| 2023-07-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-07-11 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-06-22 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-05-11 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-05-08 | 개시 | JP Morgan | Overweight |
| 2023-02-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-01-19 | 재확인 | B. Riley Securities | Neutral |
| 2022-12-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-07 | 개시 | UBS | Neutral |
| 2022-09-22 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2022-09-16 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-08 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-11 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-11-17 | 개시 | Wolfe Research | Outperform |
| 2021-11-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-10-05 | 재확인 | JP Morgan | Overweight |
| 2021-09-29 | 재확인 | Morgan Stanley | Overweight |
| 2021-09-15 | 업그레이드 | Argus | Hold → Buy |
| 2021-07-16 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-04-23 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-03-17 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-03-03 | 업그레이드 | Goldman | Sell → Buy |
| 2020-09-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-16 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2020-03-24 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2020-03-04 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2020-01-17 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-12-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-13 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-11-12 | 재확인 | B. Riley FBR | Buy |
| 2019-11-07 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-10-21 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-09-26 | 재확인 | B. Riley FBR | Buy |
| 2019-09-23 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-09-11 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-08-16 | 재확인 | BofA/Merrill | Neutral |
| 2019-07-19 | 다운그레이드 | Argus | Buy → Hold |
| 2019-07-11 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-07-09 | 다운그레이드 | Macquarie | Outperform → Neutral |
| 2019-04-22 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2019-04-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-04-02 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
모두보기
알코아 주식(AA)의 최신 뉴스
Agilent Technologies Inc (A): GF Score of 94 Signals Strong Outp - GuruFocus
Agilent Technologies price driven lower by important resistanceForecast today27-07-2026 - Economies.com
Precision Trading with Agilent Technologies Inc. (A) Risk Zones - Stock Traders Daily
Agilent Technologies, Inc. (A) Stock Analysis: Exploring A 14.97% Upside Potential - DirectorsTalk Interviews
Agilent Technologies stock steadies as investors weigh recent earnings and life-science demand trend - Ad-hoc-news.de
A|Agilent Technologies Inc|Price:138.570|Chg%:-1.185 - TradingKey
Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics? - Yahoo Finance UK
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test - Yahoo Finance
Agilent Technologies Inc (A) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Agilent Technologies Inc (A) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Agilent Technologies Inc (A) Institutional Confidence - TradingKey
Agilent Technologies Inc (A) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
What to Expect From Agilent Technologies' Q3 2026 Earnings Report - inkl
A|Agilent Technologies Inc|Price:139.760|Chg%:+6.300 - TradingKey
Agilent Technologies Inc (A) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Agilent declares Q2 2026 distribution of R$ 0.44 per unit, payable July 28 - Bitget
A Look at Agilent Technologies Inc (A) After 4.7% Gain -- GF Val - GuruFocus
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies (A) Secures EU Certification for Key Diagno - GuruFocus
Why Agilent Technologies Shares Are Rising Today - Quiver Quantitative
Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers - Moomoo
Agilent stock rises on EU approval for cancer diagnostic By Investing.com - Investing.com South Africa
Agilent stock rises on EU approval for cancer diagnostic - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test By Investing.com - Investing.com South Africa
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma - Yahoo Finance
Agilent Technologies Inc (A) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Agilent BDR program executes 5-for-1 stock split on ratio adjustment - Bitget
A4881169 Bond Profile — Key Metrics - TradingView
Agilent Technologies (A) Stock Forecast & Analyst Ratings - Moomoo
Agilent stock holds near report levels as earnings metrics stay in view - Ad-hoc-news.de
Agilent Technologies (NYSE:A) Gains Fresh FDA Momentum - Kalkine Media
Agilent Technologies stock trades steady as life sciences demand supports revenue outlook - Ad-hoc-news.de
[Latest] Global Metal Stamping Market Size/Share Worth USD 412.6 Billion by 2035 at a 4.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Michael Buckner Joins Agilent Technologies as Chief Legal Officer - Medical Product Outsourcing
Agilent Technologies stock trades steadily as investors weigh recent earnings and life sciences dema - Ad-hoc-news.de
Agilent increases HALO X-ray Technologies stake - Airports International
HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited - marketscreener.com
Agilent Technologies (A) Stock Analysis: Unlocking a 21% Upside Potential with Robust Market Presence - DirectorsTalk Interviews
Agilent Technologies (A) Wells Fargo 20th Annual Healthcare Conference 2025 Summary - Quartr
Agilent Increases Its Investment in HALO X-ray Technologies - Morningstar
Agilent Technologies (A) Wins FDA Approval, Where Does Fair Value Sit Now? - Sahm
Agilent Technologies (A) Q2 2025 earnings summary - Quartr
Agilent Technologies (A) Q1 2026 earnings summary - Quartr
Agilent Technologies stock trades steady as recent earnings and life-science demand underpin valuati - Ad-hoc-news.de
Agilent Technologies (A) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
Agilent Technologies (A) Proxy Filing Summary - Quartr
Agilent Technologies (A) Q4 2025 earnings summary - Quartr
Agilent Technologies stock holds support as results stay in focus - Ad-hoc-news.de
Agilent 1260 Infinity II LC by Agilent Technologies Inc.mid-range workhorse for routine labs - Ad-hoc-news.de
Agilent Technologies Inc (A) Stock Down 3.4% -- Now Undervalued? GF Score: 93/100 - GuruFocus
알코아 (AA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.75%
2.38%
자본화:
|
볼륨(24시간):